Study for Atrial Fibrillation Reduction (SAFARI)
Public ClinicalTrials.gov record NCT00267137. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Atrial fibrillation (AF), which is the name for rapid beats in the upper chambers of the heart, is the world's most common kind of irregular heart beat. People with AF experience symptoms such as heart palpitations (a racing or pounding feeling in the chest), shortness of breath, dizziness, fatigue or weakness. Although AF can occur in otherwise healthy people for no apparent reason, it is sometimes associated with high blood pressure, heart disease or lung problems. The purpose of the SAFARI trial is to study the effectiveness of pacing algorithms in the upper chamber of the heart for patients who have both AF and bradycardia (slow heart beat).
Study identification
- NCT ID
- NCT00267137
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 540 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2002 (Actual)
- Primary completion
- Sep 11, 2005 (Actual)
- Completion
- Jul 21, 2006 (Actual)
- Last update posted
- Feb 13, 2025
2002 – 2006
United States locations
- U.S. sites
- 34
- U.S. states
- 19
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Yuma | Arizona | — | — |
| Not listed | Fayetteville | Arkansas | — | — |
| Not listed | Fort Smith | Arkansas | — | — |
| Not listed | Bakersfield | California | — | — |
| Not listed | Berkeley | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Aurora | Colorado | — | — |
| Not listed | Stamford | Connecticut | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | Daytona Beach | Florida | — | — |
| Not listed | Ormond Beach | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Lombard | Illinois | — | — |
| Not listed | Springfield | Illinois | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Brighton | Massachusetts | — | — |
| Not listed | Lansing | Michigan | — | — |
| Not listed | Saint Paul | Minnesota | — | — |
| Not listed | Paterson | New Jersey | — | — |
| Not listed | Ridgewood | New Jersey | — | — |
| Not listed | East Syracuse | New York | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Syracuse | New York | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Cleveland | Ohio | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Elyria | Ohio | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Charleston | South Carolina | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Houston | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00267137, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 13, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00267137 live on ClinicalTrials.gov.